| 1.78 0.12 (7.23%) | 08-18 16:00 | |||||||||||||
|
|
| Short term |   |
|||
| Mid term | |
|||
| Targets | 6-month : | 2.14 |
1-year : | 2.51 |
| Resists | First : | 1.84 |
Second : | 2.14 |
| Pivot price | 1.7 |
|||
| Supports | First : | 1.69 |
Second : | 1.61 |
| MAs | MA(5) : | 1.73 |
MA(20) : | 1.69 |
| MA(100) : | 1.84  |
MA(250) : | 4.27 |
|
| MACD | MACD : | 0 |
Signal : | -0.1 |
| %K %D | K(14,3) : | 51.3 |
D(3) : | 60.3 |
| RSI | RSI(14): 54.8 |
|||
| 52-week | High : | 25.5 | Low : | 1.18 |
Price has closed above its short-term moving average. Short-term moving average is currently above mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BULLISH in short-term; and NEUTRAL in mid-long term.[ HSDT ] has closed below upper band by 6.4%. Bollinger Bands are 62.2% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 22 bars. This is a sign that the market may be about to initiate a new trend.
| If tomorrow: | Open lower | Open higher |
| High: | 1.79 - 1.8 | 1.8 - 1.81 |
| Low: | 1.6 - 1.61 | 1.61 - 1.62 |
| Close: | 1.76 - 1.78 | 1.78 - 1.8 |
Solana Co. is a medical device firm specializing in neurotechnology, dedicated to improving neurological wellness. The company's strategy involves developing, licensing, and acquiring innovative, non-invasive platform technologies. These technologies are designed to enhance the brain's intrinsic capacity for self-healing and mitigate the effects of neurological diseases or trauma. A prime example of their work is the development of an investigational portable neuromodulation stimulator. This device uniquely delivers neurostimulation through the tongue. Clinical studies have indicated that this approach significantly enhances the efficacy of physical exercises for individuals experiencing neurological symptoms stemming from conditions like disease or trauma, including mild-to-moderate traumatic brain injury. Established on March 13, 2014, Solana Co. maintains its headquarters in Newtown, Pennsylvania.
Mon, 17 Aug 2026
Solana Company 2026 Q2 - Results - Earnings Call Presentation (NASDAQ:HSDT) 2026-08-17 - Seeking Alpha
Mon, 17 Aug 2026
Solana (NASDAQ:HSDT) Given New $2.50 Price Target at B. Riley Financial - marketbeat.com
Sat, 15 Aug 2026
Solana Company Q2 Loss Hits $30.3 Million as SOL Treasury Suffers - Yahoo Finance
Sat, 15 Aug 2026
Solana Company Reports Q2 Loss as SOL Write-Downs Pressure HSDT Stock - tokenpost.com
Fri, 14 Aug 2026
Solana Q2 Earnings Call Highlights - TradingView
Fri, 14 Aug 2026
Solana Company Q2 2026 slides: revenue misses but infrastructure gains - Investing.com
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Outperform |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Underperform |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Underperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Underperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Underperform |
|
Exchange:
NASDAQ
|
|
|
Sector:
Financial Services
|
|
|
Industry:
Asset Management
|
|
| Shares Out | -346 (M) |
| Shares Float | 0 (M) |
| Held by Insiders | 5.839e+007 (%) |
| Held by Institutions | 4.144e+007 (%) |
| Shares Short | 0 (K) |
| Shares Short P.Month | 0 (K) |
| EPS | 9.03e+006 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 379.14 |
| Profit Margin | 0 % |
| Operating Margin | -2 % |
| Return on Assets (ttm) | 751.1 % |
| Return on Equity (ttm) | -207.9 % |
| Qtrly Rev. Growth | 9.59e+006 % |
| Gross Profit (p.s.) | 277.81 |
| Sales Per Share | 980208 |
| EBITDA (p.s.) | 486458 |
| Qtrly Earnings Growth | -3.386e+008 % |
| Operating Cash Flow | 0 (M) |
| Levered Free Cash Flow | 0 (M) |
| PE Ratio | 0 |
| PEG Ratio | 0 |
| Price to Book value | 0 |
| Price to Sales | 0 |
| Price to Cash Flow | 0 |
| Dividend | 1.16e+006 |
| Forward Dividend | 1.26e+006 |
| Dividend Yield | 65168500% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|